Skip to main content

Table 2 Gleason grade group according to PSA level at diagnosis (ng/ml) among patients with prostate cancer, (N = 452), from the Martinique Cancer Registry, 2013

From: Pattern of care of prostate cancer patients across the Martinique: results of a population-based study in the Caribbean

 

<  4

(n = 19)

4 ≥ PSA > 10

(n = 263)

10 ≥ PSA > 20

(n = 95)

20 ≥ PSA > 100

(n = 46)

≥ 100

P

(n = 29)

n

%

n

%

n

%

n

%

n

%

Gleason grade group (N = 447)

          

–

 Group 1 (3 + 3)

5

26.3

116

44.8

26

27.4

5

11.1

–

–

 

 Group 2 (3 + 4)

9

47.4

74

28.6

29

30.5

5

11.1

–

–

 

 Group 3 (4 + 3)

4

21.0

40

15.4

24

25.2

13

28.9

3

10.3

 

 Group 4 (8)

1

5.3

19

7.3

11

11.6

9

20.0

8

27.6

 

 Group 5 (9 or 10)

–

–

10

3.9

5

5.3

13

28.9

18

62.1

 

 Unknown

–

–

4

–

–

–

1

–

–

–

Â